NCT00003297View on ClinicalTrials.gov

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 1997

Primary Completion Date

January 31, 2001

Study Completion Date

January 31, 2001

Conditions
Ovarian Cancer
Interventions
DRUG

mitoxantrone hydrochloride

DRUG

thiotepa

DRUG

topotecan hydrochloride

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

20007

Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington D.C.

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Georgetown University

OTHER

NCT00003297 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer | Biotech Hunter | Biotech Hunter